Annual pen testing fits a budget cycle but it doesn't reflect how fast manufacturing environments actually change.

21 CFR Part 11 and cGMP don't mention penetration testing but the controls they require depend on it.

R&D and GxP regulated environments have different risk profiles, compliance requirements, and testing constraints.

Nation-state actors treat pharma like critical infrastructure targeting formulation data, synthesis routes, and clinical IP with patience and precision.

Ransomware operators target the IT-OT boundary deliberately and they know manufacturing economics well.

Industry 4.0 connected OT environments were never built for. Learn why traditional IT security tools fall short and what OT penetration testing reveals that audits miss.

Manufacturing faces a 2.1M skilled worker shortage by 2030.

Discover what AS4 actually solves for modern businesses. Learn the real outcomes companies achieve after migration, from stronger security to better B2B integration performance.

Avoid costly AS4 upgrade mistakes. Discover 7 migration pitfalls that delay projects, create risk, and disrupt B2B messaging, plus practical ways to avoid them.